Oral Mucositis in Cancer and Potential Use of Omega-3 Free Fatty Acids in Its Management: A Review
aut.relation.endpage | 1531 | |
aut.relation.issue | 11 | en_NZ |
aut.relation.journal | Biomedicines | en_NZ |
aut.relation.startpage | 1531 | |
aut.relation.volume | 9 | en_NZ |
aut.researcher | Lu, Jun | |
dc.contributor.author | Lessa, RC | en_NZ |
dc.contributor.author | Alves, FDA | en_NZ |
dc.contributor.author | Fortunati, E | en_NZ |
dc.contributor.author | Lu, J | en_NZ |
dc.date.accessioned | 2022-03-21T03:24:33Z | |
dc.date.available | 2022-03-21T03:24:33Z | |
dc.date.copyright | 2021 | en_NZ |
dc.date.issued | 2021 | en_NZ |
dc.description.abstract | Oral mucositis (OM) is a painful condition caused by chemotherapeutic or radiotherapeutic cancer treatments, occurring in patients with different tumour characteristics and locations. OM greatly impacts a patient’s quality of life and cancer recovery. Current OM management strategies are not providing sufficient prevention and treatment; new approaches to injury management are needed. Studies on the benefit of omega-3 free fatty acids (FFA) in human health have increased significantly in recent years. FFA properties have been studied extensively, including their potential therapeutic use in inflammatory conditions. However, omega-3 FFA’s use as a supplementary treatment for OM has not been clinically tested. Preliminary evidence suggests that utilising FFA to manage OM could be a useful strategy for lesion management, assisting with healthy oral mucosa recovery. This review will describe the incidence, risk factors, biology of OM and the current treatment strategies, leading to a discussion of the utility of omega-3 FFA as a novel therapeutic agent for OM. | en_NZ |
dc.identifier.citation | Biomedicines, 9(11), 1531. https://doi.org/10.3390/biomedicines9111531 | |
dc.identifier.doi | 10.3390/biomedicines9111531 | en_NZ |
dc.identifier.issn | 2227-9059 | en_NZ |
dc.identifier.uri | https://hdl.handle.net/10292/15009 | |
dc.language | en | en_NZ |
dc.publisher | MDPI AG | en_NZ |
dc.relation.uri | https://www.mdpi.com/2227-9059/9/11/1531 | |
dc.rights | © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/). | |
dc.rights.accessrights | OpenAccess | en_NZ |
dc.subject | Oral mucositis; Inflammation; Polyunsaturated fatty acids; Omega-3 fatty acids; Omega-6 fatty acids; Cancer; Prostaglandins; Leukotrienes; Interleukins; Cytokines | |
dc.title | Oral Mucositis in Cancer and Potential Use of Omega-3 Free Fatty Acids in Its Management: A Review | en_NZ |
dc.type | Journal Article | |
pubs.elements-id | 442697 | |
pubs.organisational-data | /AUT | |
pubs.organisational-data | /AUT/Faculty of Health & Environmental Science | |
pubs.organisational-data | /AUT/Faculty of Health & Environmental Science/School of Public Health & Interdisciplinary Studies | |
pubs.organisational-data | /AUT/Faculty of Health & Environmental Science/School of Public Health & Interdisciplinary Studies/Biosciences Department | |
pubs.organisational-data | /AUT/PBRF | |
pubs.organisational-data | /AUT/PBRF/PBRF Health and Environmental Sciences | |
pubs.organisational-data | /AUT/PBRF/PBRF Health and Environmental Sciences/HI Interprofessional 2018 PBRF |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Oral Mucositis in Cancer and Potential Use of Omega-3 Free Fatty Acids in Its Management A Review.pdf
- Size:
- 1.61 MB
- Format:
- Adobe Portable Document Format
- Description:
- Journal article
License bundle
1 - 1 of 1
Loading...
- Name:
- AUT Grant of Licence for Tuwhera Jun 2021.pdf
- Size:
- 360.95 KB
- Format:
- Adobe Portable Document Format
- Description: